Meeting
2023 ASCO Genitourinary Cancers Symposium
Genomic alterations in metastatic renal cell carcinoma (mRCC): Impact on survival and clinical outcomes.
Authors
Jennifer King
Indiana University, Indianapolis, IN
Jennifer King , Rebecca Hassoun , Sandra K. Althouse , Christopher A. Fausel , Bryan P. Schneider , Theodore F. Logan , Nabil Adra
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 700)
DOI
10.1200/JCO.2023.41.6_suppl.700
Abstract #
700
Poster Bd #
J13
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Comparing molecular variations and outcomes in Hispanic and non-Hispanic patients with metastatic clear cell renal cell carcinoma (ccRCC).
First Author: Sharon Choi
Poster
2019 ASCO Quality Care Symposium
Efficacy of systemic treatment for metastatic renal cell carcinoma (mRCC) guided by comprehensive genomic profiling (CGP).
First Author: Paulo Gustavo Bergerot
Poster
2018 Genitourinary Cancers Symposium
Genomic alterations to refine prognostication of patients with metastatic renal cell carcinoma.
First Author: Dominick Bosse
Poster
2016 Genitourinary Cancers Symposium
Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.
First Author: Xiao Bi